Johan Wallin

2.2k total citations
33 papers, 1.7k citations indexed

About

Johan Wallin is a scholar working on Immunology, Molecular Biology and Neurology. According to data from OpenAlex, Johan Wallin has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Johan Wallin's work include T-cell and B-cell Immunology (14 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Johan Wallin is often cited by papers focused on T-cell and B-cell Immunology (14 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Johan Wallin collaborates with scholars based in Sweden, Germany and United Kingdom. Johan Wallin's co-authors include Rudi Balling, Haruhiko Koseki, Jörg Wilting, Bodo Christ, Bengt Linderoth, E Möller, Björn A. Meyerson, R. Fritsch, Jan Böhme and Hermann Eibel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Development.

In The Last Decade

Johan Wallin

33 papers receiving 1.7k citations

Peers

Countries citing papers authored by Johan Wallin

Since Specialization

Citations

This map shows the geographic impact of Johan Wallin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Wallin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Wallin more than expected).

Fields of papers citing papers by Johan Wallin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Wallin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Wallin. The network helps show where Johan Wallin may publish in the future.

Co-authorship network of co-authors of Johan Wallin

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Wallin. A scholar is included among the top collaborators of Johan Wallin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Wallin. Johan Wallin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [¹¹C]PBR28 PET 2025 ·Movement Disorders ·Johan Wallin, Anton Forsberg, Per Svenningsson	5
2	Montelukast alleviates neuroinflammation and improves motor functions in the line 61 model of Parkinson's disease: An exploratory study 2025 ·Neurotherapeutics ·(unknown), (unknown), Heike Mrowetz, Michael S. Unger, (unknown), Barbara Altendorfer, Joerg Neddens, Stefanie Flunkert, Birgit Hutter‐Paier, (unknown), Johan Wallin, Rodolphe Poupardin, (unknown), (unknown), (unknown), Thomas K. Felder, Per Svenningsson, Ludwig Aigner	1
3	β2‐Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk 2023 ·Annals of Neurology ·Bojing Liu, Per Svenningsson, Jonas F. Ludvigsson, Cecilia Lundholm, Johan Wallin, Henrik Larsson, Arvid Sjölander, Dylan M. Williams, Nancy L. Pedersen, Karin Wirdefeldt	7
4	[¹¹C]PBB3 binding in Aβ(–) or Aβ(+) corticobasal syndrome 2023 ·Synapse ·Zsolt Cselényi, Johan Wallin, (unknown), B. Bloth, Samuel Svensson, Inger Nennesmo, Dan Sunnemark, Vesna Jelić, Lars Farde, Per Svenningsson	1
5	Development of the Skeletal System 2007 ·Novartis Foundation symposium ·Rudi Balling, (unknown), Susanne Dietrich, Johan Wallin, (unknown)	5
6	Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat 2006 ·Neuroscience Letters ·C. Ultenius, Bengt Linderoth, Björn A. Meyerson, Johan Wallin	112
7	Intrathecal Clonidine Potentiates Suppression of Tactile Hypersensitivity by Spinal Cord Stimulation in a Model of Neuropathy 2004 ·Anesthesia & Analgesia ·Gastón Schechtmann, Johan Wallin, Björn A. Meyerson, Bengt Linderoth	38
8	Spinal cord stimulation inhibits long-term potentiation of spinal wide dynamic range neurons 2003 ·Brain Research ·Johan Wallin, (unknown), Arne Tjølsen, Bengt Linderoth, Kjell Hole	55
9	Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy 2002 ·European Journal of Pain ·Johan Wallin, Jianguo Cui, Vadim Yakhnitsa, Gastón Schechtmann, Björn A. Meyerson, Bengt Linderoth	92
10	Substance P release in the spinal dorsal horn following peripheral nerve injury 2002 ·Neuropeptides ·Johan Wallin, (unknown)	13
11	Pax-1 in the development of the cervico-occipital transitional zone 1995 ·Anatomy and Embryology ·J�rg Wilting, Cecilia Ebensperger, (unknown), Haruhiko Koseki, Johan Wallin, Bodo Christ	31
12	The role of Pax-1 in axial skeleton development 1994 ·Development ·Johan Wallin, Jörg Wilting, Haruhiko Koseki, R. Fritsch, Bodo Christ, Rudi Balling	279
13	A new Pax gene, Pax-9, maps to mouse Chromosome 12 1993 ·Mammalian Genome ·Johan Wallin, Yoko Mizutani, Kenji Imai, (unknown), Kazuo Moriwaki, Masaru Taniguchi, Haruhiko Koseki, Rudi Balling	42
14	Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with t cell receptor β chain gene alleles or haplotypes 1991 ·Arthritis & Rheumatism ·Johan Wallin, (unknown), Olle Olerup, (unknown), Håkan Ström, (unknown), (unknown), (unknown)	33
15	Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis 1990 ·Immunogenetics ·(unknown), Johan Wallin, Ritva Pirskanen, Georg Matell, Smith Rjh	54
16	Specificity of HLA restricting elements for human nickel reactive T cell clones 1989 ·Tissue Antigens ·Lennart Emtestam, (unknown), Jan A. Marcusson, Johan Wallin, E Möller	15
17	Individuals with HLA‐DR blank alleles display well‐known DR‐DQ RFLPs 1989 ·Tissue Antigens ·Johan Wallin, (unknown), O Olerup, E Möller	6
18	A dr4‐associated dr‐dq haplotype is significantly associated with rheumatoid arthritis 1988 ·Arthritis & Rheumatism ·Johan Wallin, (unknown), (unknown), (unknown)	32
19	Genomic typing for HLA class II antigens: application to matching of renal allografts. 1987 ·PubMed ·Johan Wallin, G Lundgren, E Möller, (unknown)	2
20	HLA-DR-DQ haplotypes defined by restriction fragment analysis 1987 ·Human Immunology ·(unknown), Johan Wallin, Jan Böhme, E Möller	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact